Evaluation of Hematological and Biochemical Parameters that Predict the No-reflow Phenomenon in Patients Undergoing Primary Percutaneous Coronary Intervention

被引:0
|
作者
Aydemir, Selim [1 ]
Aydin, Sidar Siyar [2 ]
Altinkaya, Onur [1 ]
Aksakal, Emrah [1 ]
Ozmen, Murat [1 ]
机构
[1] Univ Hlth Sci, Erzurum City Hosp, Dept Cardiol, TR-25080 Erzurum, Turkiye
[2] Ataturk Univ, Fac Med, Dept Cardiol, Erzurum, Turkiye
关键词
acute coronary syndrome; no-reflow phenomenon; primary percutaneous coronary intervention; ELEVATION MYOCARDIAL-INFARCTION; TO-LYMPHOCYTE RATIO; CELL DISTRIBUTION WIDTH; ADVERSE CARDIAC EVENTS; LONG-TERM OUTCOMES; MICROVASCULAR OBSTRUCTION; NEUTROPHIL/LYMPHOCYTE RATIO; D-DIMER; NEUTROPHIL; MORTALITY;
D O I
10.1177/00033197251320141
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Acute coronary syndromes (ACS) are one of the most common causes of morbidity and mortality worldwide. Primary percutaneous coronary intervention (pPCI) is the main treatment strategy to restore myocardial perfusion. However, the no-reflow phenomenon (NRP) may block coronary flow. The present study focused on assessing and contrasting predictive parameters for NRP in ACS patients. Our research is a retrospective analysis. We assessed the parameters significantly associated with NRP using Cox regression and Receiver operating characteristic (ROC) Curve analysis. The study included 5122 patients who met the criteria. The average age of the patients was 63.9 + 13.2, and 74.4% were male. It was observed that NRP developed in 1.8% of all patients. Age, hemoglobin (Hb), white blood cell (WBC), glucose and low density lipoprotein cholesterol (LDL-C) were determined to be independent predictors of NRP. The power of these parameters to predict NRP was similar, and WBC was the most predictive (Area Under Curve (AUC): 0.605 95% CI: 0.539-0.671, P = .001). We believe that the use of these simple, practical, and routinely used hematological and biochemical parameters will help us predict the risk of developing NRP before pPCI. This information should improve management.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Prevalence and prognostic implications of the no-reflow phenomenon in patients undergoing primary percutaneous coronary intervention in a university center in a middle-income country
    Godinez Cordova, L. B.
    Gonzalez-Pacheco, H.
    Gopar-Nieto, R.
    Eid-Lidt, G.
    Briseno-De La Cruz, J. L.
    Araiza-Garaygordobil, D.
    Mendoza-Garcia, S.
    Altamirano-Castillo, A.
    Ontiveros-Mercado, H.
    Arias-Mendoza, A.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2066 - 2066
  • [22] RISK FACTORS FOR NO-REFLOW PHENOMENON AFTER PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ACUTE CORONARY SYNDROME
    Liang, Tian
    Liu, Min
    Wu, Chengyu
    Zhang, Qing
    Lu, Lei
    Wang, Zhongliang
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2017, 69 (03): : 139 - 145
  • [23] The no-reflow phenomenon associated with percutaneous coronary intervention: Its mechanisms and treatment
    Ito H.
    Cardiovascular Intervention and Therapeutics, 2011, 26 (1) : 2 - 11
  • [24] Risk Factors of No-Reflow Phenomenon after Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction Female Patients
    Lu, D. B.
    Chen, Z. W.
    Yu, Z. Q.
    Xia, Y.
    Chen, A.
    Shu, X. H.
    Qian, J. Y.
    Ge, J. B.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2018, 66 : S486 - S486
  • [25] Simple clinical risk score for no-reflow prediction in patients undergoing primary Percutaneous Coronary Intervention with acute STEMI
    Dogan, Nazile Bilgin
    Ozpelit, Ebru
    Akdeniz, Selma
    Bilgin, Muzaffer
    Baris, Nezihi
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2015, 31 (03) : 576 - 581
  • [26] Evaluation of the clinical, angiographic and electrocardiographic features associated with no-reflow phenomenon in patients undergoing coronary intervention for any indication
    Vargas Saenz, E. A.
    Medina Jutinico, M. A.
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2013, 12 : S58 - S59
  • [27] Serum Endocan Levels Predict Angiographic No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Coronary Intervention
    Dogdus, Mustafa
    Yenercag, Mustafa
    Ozyasar, Mehmet
    Yilmaz, Ahmet
    Can, Levent Hurkan
    Kultursay, Hakan
    ANGIOLOGY, 2021, 72 (03) : 221 - 227
  • [28] Comparative Efficacy of Prophylactic Intracoronary Nikorandil versus Diltiazem in Prevention of Slow Reflow and No-Reflow in Patients Undergoing Primary Percutaneous Coronary Intervention
    Fischer, Louie
    Jacob, Anitha
    George, Jimmy
    Binny, Pushpa Prabha
    Punnose, Eapen
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (07): : 68S - 68S
  • [29] The Systemic Immune Inflammatory Index Predicts No-Reflow Phenomenon after Primary Percutaneous Coronary Intervention in Older Patients with STEMI
    Wang, Jiaqi
    Zhang, Feifei
    Gao, Man
    Wang, Yudan
    Song, Xuelian
    Li, Yingxiao
    Dang, Yi
    Qi, Xiaoyong
    CARDIOVASCULAR INNOVATIONS AND APPLICATIONS, 2022, 7 (01)
  • [30] Factors influencing no-reflow phenomenon in patients with ST-segment myocardial infarction treated with primary percutaneous coronary intervention
    Djenic, Nemanja
    Dzudovic, Boris
    Romanovic, Radoslav
    Ratkovic, Nenad
    Jovic, Zoran
    Djukic, Bosko
    Spasic, Marijan
    Stojkovic, Sinisa
    Obradovic, Slobodan
    VOJNOSANITETSKI PREGLED, 2018, 75 (10) : 1009 - 1013